The number of microneedling sessions required varies based on individual skin conditions and desired results. Typically, a series of multiple treatments spaced a few weeks apart is recommended for optimal results. During your consultation, our experienced practitioners will assess your skin and develop a personalized treatment plan.

Microneedling is generally well-tolerated. While the procedure involves some discomfort, the application of a topical numbing cream significantly reduces any pain. Most clients report only mild sensations during the treatment.

Microneedling involves minimal downtime. Post-treatment redness and swelling typically subside within a few days. You can resume your normal activities immediately, but it’s crucial to avoid sun exposure until your skin has fully healed.

Microneedling stimulates the production of collagen and elastin, resulting in long-lasting improvements to the skin’s texture and appearance. With proper skin care and maintenance, the results can be sustained over time.

The following risks are associated with FDA-authorized uses of microneedling devices.

Common risks include:

• Dryness

• Rough skin

• Tightness

• Redness

• Itching

• Peeling

• Discomfort

• Burning

• Bruising

• Bleeding

• Crusting

Less common risks include:

• Pigmentation changes (increase in pigment (hyperpigmentation) or loss of pigment (hypopigmentation)

• Lines on the face

• Reactivation of herpes cold sores

• Swollen lymph nodes

• Infection

• Stinging or itching when cosmetic products are applied

Before your microneedling appointment, it’s essential to inform your medical provider about any medications, supplements, or skin conditions you have. Avoid using any harsh skincare products or treatments before the procedure. During your consultation, our practitioners will provide specific pre-treatment instructions to ensure the best results.

• Have a known history of clotting or bleeding disorders such as hemophilia.

• Are immune deficient or immune suppressed due to medical conditions or medications.

• Suffer from uncontrolled diabetes (high blood sugar).

• Take anticoagulant (blood thinner) therapies such as warfarin,heparin, or low dose aspirin.

• Suffer from an active skin infection, including bacterial, viral, or fungal infection.

• Suffer from an infection such as hepatitis or human immunodeficiency virus (HIV).

• Have or had eczema, psoriasis, vitiligo, or auto-immune disease.

• Have an active rash on the face.

• Have a current outbreak of cold sores (herpes).

• Are currently taking acne medication with the ingredient isotretinoin (Accutane) or have taken isotretinoin in the past 6 months.

• Have actinic (solar) keratoses, keloid scars (or a history of keloid scars), warts, , or birthmarks or moles in the treatment area.

• Have darker skin type, as there is a risk of darkening or lightening of the skin after the procedure. Some of the devices authorized for marketing by the FDA were not studied in subjects with darker skin types.

• Are tan or planning to be in the sun in the two weeks following the procedure.

• Suffer from a known malignancy or are undergoing or about to undergo treatments using chemotherapy, radiotherapy, or steroids.

• Are pregnant or breastfeeding.

• Are allergic to stainless steel or to topical or local anesthetics or have a history of contact dermatitis to these products.